Form4insider filings, from the source

Insider holders · CIK 0001177648

ENANTA PHARMACEUTICALS INC · ENTA

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Jay R. LulyPresident and CEO631,194—631,194Feb 13, 2019 · 9:16 pm ESTForm 4
Yat Sun OrSr. VP & CSO300,673—300,673Mar 4, 2019 · 6:14 pm ESTForm 4
Paul J MellettTreasurer and CFO97,188—97,188Feb 25, 2019 · 4:18 pm ESTForm 4
Nathaniel S. GardinerSr. VP & General Counsel26,497—26,497Mar 7, 2019 · 4:20 pm ESTForm 4
Scott T. RottinghausChief Medical Officer23,787—23,787Aug 10, 2026 · 9:00 am EDTForm 4
Tim OcainSenior Vice President17,547—17,547Feb 13, 2019 · 9:40 pm ESTForm 4
Terry VanceDirector15,295—15,295Feb 17, 2016 · 10:07 am ESTForm 4
Nathalie AddaSr. VP & Chief Medical Officer10,394—10,394Feb 13, 2019 · 9:33 pm ESTForm 4
Stephen Buckley Jr.Director2,000—2,000Feb 19, 2015 · 4:22 pm ESTForm 4
George GolumbeskiDirector0—0Mar 6, 2019 · 4:51 pm ESTForm 4
Bruce L A CarterDirector0—0Mar 12, 2019 · 4:51 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.